|
|
||||||||
Ann Thorac Surg 1990;49:363-369
© 1990 The Society of Thoracic Surgeons
Surgery Branch and Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
* Address reprint requests to Dr Pass, Thoracic Oncology Section, Surgery Branch, National Cancer Institute/NIH, Bldg 10, Room 2B07, Bethesda, MD 20892.
Indications for chest wall resection of metastatic or locally recurrent sarcoma and for subsequent bony reconstruction are controversial. Twenty-eight patients had chest wall resection for high-grade primary, metastatic, or recurrent sarcoma. In all patients, resection with selective reconstruction of the bony thorax was performed without operative mortality. Since 1980, only patients with four or more ribs resected have had selective bony reconstruction. Follow-up ranged from 8 to 132 months (median follow-up, 42 months). All deaths were related to sarcoma recurrence. The overall actuarial survival rate was 85% at 1 year, 65% at 3 years, and 59% at more than 5 years. The overall actuarial proportion without disease recurrence was 64% at 1 year, 52% at 3 years, and 40% at more than 5 years. There was no significant difference in overall or disease-free survival for patients with primary, metastatic, or recurrent tumors. The most important prognostic factors were positive margins and concomitant pulmonary resection for synchronous lung metastases. These data support aggressive resection to obtain pathologically tumor-free margins for chest wall sarcomas, whether primary, metastatic, or recurrent. Reconstruction can be individualized based on the extent of resection.
This article has been cited by other articles:
![]() |
S.-H. Hemmati, A. M. Correa, G. L. Walsh, S. G. Swisher, J. A. Roth, D. C. Rice, R. J. Mehran, and A. A. Vaporciyan The prognostic factors of chest wall metastasis resection Eur J Cardiothorac Surg, August 1, 2011; 40(2): 328 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Heuker, B. Lengele, V. Delecluse, B. Weynand, G. Liistro, B. Balduyck, P. Noirhomme, and A. J. Poncelet Subjective and objective assessment of quality of life after chest wall resection Eur J Cardiothorac Surg, January 1, 2011; 39(1): 102 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Wouters, A. N. van Geel, L. Nieuwenhuis, H. van Tinteren, C. Verhoef, F. van Coevorden, and H. M. Klomp Outcome After Surgical Resections of Recurrent Chest Wall Sarcomas J. Clin. Oncol., November 1, 2008; 26(31): 5113 - 5118. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Walsh, B. M. Davis, S. G. Swisher, A. A. Vaporciyan, W. R. Smythe, K. Willis-Merriman, J. A. Roth, and J. B. Putnam Jr A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0048 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Allen, D. L. Miller, C. Deschamps, V. F. Trastek, and P. C. Pairolero Chest wall tumors Ann. Thorac. Surg., March 1, 1999; 67(3): 889 - 890. [Full Text] [PDF] |
||||
![]() |
M. Incarbone, M. Nava, C. Lequaglie, G. Ravasi, and U. Pastorino STERNAL RESECTION FOR PRIMARY OR SECONDARY TUMORS J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 93 - 99. [Abstract] [Full Text] |
||||
![]() |
F. Puma, M. Ragusa, and G. Daddi Chest wall stabilization with synthetic reabsorbable material Ann. Thorac. Surg., March 1, 1992; 53(3): 408 - 411. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |